4 results match your criteria: "PLA Rocket Force Medical Center[Affiliation]"
Efficacy of percutaneous vertebroplasty using cross-puncture in the treatment of Genant grade 0-1 osteoporotic vertebral compression fractures.
World Neurosurg
December 2024
Department of Orthopaedics, PLA Rocket Force Medical Center, Beijing, 100088, China. Electronic address:
Background: Percutaneous vertebroplasty (PVP) is a common surgical method for osteoporotic vertebral compression fracture (OVCFs). The puncture method and location of the puncture needle can directly affect bone cement distribution in the vertebra. This retrospective study aimed to compare the clinical efficacy and safety of PVP using the cross-puncture and bilateral conventional puncture for the treatment of Genant grade 0-1 OVCFs.
View Article and Find Full Text PDFExistence and distribution of the microbiome in tumour tissues of children with hepatoblastoma.
Heliyon
November 2024
Capital Institute of Pediatrics, Beijing, 100020, China.
Article Synopsis
- - Recent research has identified cancer-associated microbiota in various cancers, influencing inflammation, tumor development, and treatment resistance, particularly in hepatoblastoma (HB), a common childhood cancer.
- - A study using 16S rDNA sequencing revealed significant differences in microbiome diversity and abundance between HB tumor tissues and adjacent non-tumor tissues, with Proteobacteria, Bacteroidetes, and Firmicutes being prevalent in tumors.
- - Specific bacterial communities showed potential correlations with HB development and associated markers, suggesting they could serve as indicators of the disease, warranting further investigation into the role of the microbiome in HB.
Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials.
Front Pharmacol
September 2024
Pharmaceutical Department, PLA Strategic Support Force Medical Center, Beijing, China.
Article Synopsis
- The study evaluates the effectiveness and safety of etrasimod, an S1PR modulator, in treating adults with ulcerative colitis during the induction phase through a meta-analysis of randomized controlled trials.
- Researchers analyzed data from three studies involving 943 patients, focusing on clinical remission rates at 12 weeks and several secondary health outcomes, along with the frequency of adverse effects.
- Results showed etrasimod significantly improved clinical remission and other health outcomes compared to placebo, while the occurrence of adverse effects was similar between both groups, indicating it may be a safe treatment option.
Repeat hepatectomy for pediatric recurrent chemotherapy-resistant hepatoblastoma: a report of 18 cases.
J Cancer Res Clin Oncol
July 2023
Postgraduate Base of the PLA Rocket Force Medical Center, Jinzhou Medical University, Jinzhou, 121001, Liaoning Province, China.
Background And Aims: Repeat hepatectomy for adult recurrent hepatocellular carcinoma significantly prolongs the overall survival, but repeat hepatectomy for pediatric recurrent hepatoblastoma (HB) is rarely reported, and the outcomes are warranted to be investigated.
Methods: All patients between May 2015 and December 2020 with recurrent HB after intended surgical cure were retrospectively evaluated. Clinicopathologic features, surgical details and outcomes were analyzed during a median following-up of 24 months after repeat hepatectomy.